Other Cancer

Few people are taking advantage of pills that have been proven to prevent a substantial number of common cancers. If you didn't realize such pills exist, you are not unusual. Which is part of the problem. This barely used arsenal in the war on cancer has grown to four drugs -- two for the breast and two for the prostate gland. The first won federal approval in 1998; the fourth is now seeking approval.

CEA-Leti announced the launch of the TARGET-PDT project designed to increase the effectiveness of photodynamic therapy (PDT) for treating cancer by developing a novel nano carrier-based approach.

Researchers from Cold Spring Harbor Laboratory in the USA have developed a powerful new technique for analyzing the genome of single tumor cells. The breakthrough allows them to study in fine detail the biology of how tumors develop and has the potential to help doctors identify dangerous tumor cells from small samples such as fine-needle biopsies from the prostate or a non-invasive lesion in the breast,

New investigation results, 'Cancer therapies and bone health,' are detailed in a study published in Current Rheumatology Reports. According to recent research from the United States, Cancer patients are at risk for adverse events involving bone. Metastasis of cancer to bone and primary bone tumors can compromise the integrity of bone.

A team of University of California, San Diego School of Medicine researchers has discovered that common intestinal bacteria appear to promote tumor growths in genetically susceptible mice, but that tumorigenesis can be suppressed if the mice are exposed to an inhibiting protein enzyme.

According to recent research from the United States, Of review Chemoradiation has become a common approach in the treatment of advanced head and neck cancer. Its effectiveness in eradicating associated nodal metastases has resulted in modifications in the traditional paradigms for managing this aspect.

A new study, 'Utility of influenza vaccination for oncology patients,' is now available. Every fall and winter, patients with cancer and their families ask oncologists whether they should be vaccinated for influenza. This season, with escalating concerns regarding the novel H1N1 influenza virus and its recently approved vaccine, this question has become more frequent and increasingly urgent, scientists in the United States report.

Researchers detail in 'Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle,' new data in hepatocellular cancer. According to a study from Milan, Italy, The advent of molecular medicine that targets specific pathways is changing the therapeutic approach to hepatocellular carcinoma.

The International Journal of Epidemiology today published a combined data analysis from a multi national population-based case-control study of glioma and meningioma, the most common types of brain tumour. This is the first in a series of combined data analyses of head and neck tumours published as part of the internationally coordinated INTERPHONE project.

University of Miami doctors have developed a new method of catching and killing tumor cells floating through the human bloodstream they say could be a potent new weapon against most kinds of cancer within a decade.